Inflammatory Marker Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Product Type (Interlukin, C Reactive Protein, Lepitine, Tumor Necrosis Factor, Cellular Adhesion Molecule, Others); Application (Tumors, Arthritis, Multiple Sclerosis, Other Applications); End User (Hospitals, Diagnostics, Research Laboratories)
Report Code: TIPRE00008999 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Inflammatory markers are used in the diagnosis of various conditions, including cancer and other chronic indications. The most commonly used inflammation marker is C-reactive protein. These help in the early detection of active systemic inflammation. Inflammatory markers are widely used in the diagnosis of cancer and autoimmune diseases.
MARKET DYNAMICS
Increasing prevalence of cancer and autoimmune disorders are major factors responsible for the increasing demand for inflammatory markers market. Cancer is the second leading cause of death worldwide. As per the WHO, in 2018, approximately 9.6 million deaths happened due to cancer. Other factors, such as an increasing number of hospitals and research laboratories, government initiatives are contributing to the growth of the market. However, lack of awareness in emerging regions may restrain the growth of the global inflammatory markers market.
MARKET SCOPE
The "Global Inflammatory Marker Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of inflammatory marker market with detailed market segmentation by product type, indications, end user and geography. The global inflammatory marker market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading inflammatory marker market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global inflammatory marker market is segmented on the basis of product type, indications and end user. Based on product type, the market is segmented into interlukin, C reactive protein, lepitine, tumor necrosis factor, cellular adhesion molecule and others. Based on indications, the market is segmented as tumors, arthritis, multiple sclerosis, and other applications. Based on end user, the market is segmented into hospitals, diagnostics, and research laboratories.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global inflammatory marker market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The inflammatory marker market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting inflammatory marker market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the inflammatory marker market in these regions.
The report covers key developments in the inflammatory marker market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from inflammatory marker market are anticipated to lucrative growth opportunities in the future with the rising demand for inflammatory marker market in the global market. Below mentioned is the list of few companies engaged in the inflammatory marker market.
The report also includes the profiles of key inflammatory marker market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Merck & Co., Inc.
- Novartis AG
- Cayman Chemical
- BODITECH MED INC
- Abbott
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific
- Orion Diagnostica Oy
- Ortho Clinical Diagnostics
- Getein Biotech, Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Inflammatory markers are used in the diagnosis of various conditions, including cancer and other chronic indications. The most commonly used inflammation marker is C-reactive protein. These help in the early detection of active systemic inflammation. Inflammatory markers are widely used in the diagnosis of cancer and autoimmune diseases.
MARKET DYNAMICS
Increasing prevalence of cancer and autoimmune disorders are major factors responsible for the increasing demand for inflammatory markers market. Cancer is the second leading cause of death worldwide. As per the WHO, in 2018, approximately 9.6 million deaths happened due to cancer. Other factors, such as an increasing number of hospitals and research laboratories, government initiatives are contributing to the growth of the market. However, lack of awareness in emerging regions may restrain the growth of the global inflammatory markers market.
MARKET SCOPE
The "Global Inflammatory Marker Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of inflammatory marker market with detailed market segmentation by product type, indications, end user and geography. The global inflammatory marker market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading inflammatory marker market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global inflammatory marker market is segmented on the basis of product type, indications and end user. Based on product type, the market is segmented into interlukin, C reactive protein, lepitine, tumor necrosis factor, cellular adhesion molecule and others. Based on indications, the market is segmented as tumors, arthritis, multiple sclerosis, and other applications. Based on end user, the market is segmented into hospitals, diagnostics, and research laboratories.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global inflammatory marker market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The inflammatory marker market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting inflammatory marker market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the inflammatory marker market in these regions.
The report covers key developments in the inflammatory marker market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from inflammatory marker market are anticipated to lucrative growth opportunities in the future with the rising demand for inflammatory marker market in the global market. Below mentioned is the list of few companies engaged in the inflammatory marker market.
The report also includes the profiles of key inflammatory marker market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Merck & Co., Inc.
- Novartis AG
- Cayman Chemical
- BODITECH MED INC
- Abbott
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific
- Orion Diagnostica Oy
- Ortho Clinical Diagnostics
- Getein Biotech, Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Inflammatory Marker Market - By Product Type
1.3.2 Inflammatory Marker Market - By Application
1.3.3 Inflammatory Marker Market - By End User
1.3.4 Inflammatory Marker Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFLAMMATORY MARKER MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INFLAMMATORY MARKER MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. INFLAMMATORY MARKER MARKET - GLOBAL MARKET ANALYSIS
6.1. INFLAMMATORY MARKER - GLOBAL MARKET OVERVIEW
6.2. INFLAMMATORY MARKER - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INFLAMMATORY MARKER MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. INTERLUKIN
7.3.1. Overview
7.3.2. Interlukin Market Forecast and Analysis
7.4. C REACTIVE PROTEIN
7.4.1. Overview
7.4.2. C Reactive Protein Market Forecast and Analysis
7.5. LEPITINE
7.5.1. Overview
7.5.2. Lepitine Market Forecast and Analysis
7.6. TUMOR NECROSIS FACTOR
7.6.1. Overview
7.6.2. Tumor Necrosis Factor Market Forecast and Analysis
7.7. CELLULAR ADHESION MOLECULE
7.7.1. Overview
7.7.2. Cellular Adhesion Molecule Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. INFLAMMATORY MARKER MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. TUMORS
8.3.1. Overview
8.3.2. Tumors Market Forecast and Analysis
8.4. ARTHRITIS
8.4.1. Overview
8.4.2. Arthritis Market Forecast and Analysis
8.5. MULTIPLE SCLEROSIS
8.5.1. Overview
8.5.2. Multiple Sclerosis Market Forecast and Analysis
8.6. OTHER APPLICATIONS
8.6.1. Overview
8.6.2. Other Applications Market Forecast and Analysis
9. INFLAMMATORY MARKER MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTICS
9.4.1. Overview
9.4.2. Diagnostics Market Forecast and Analysis
9.5. RESEARCH LABORATORIES
9.5.1. Overview
9.5.2. Research Laboratories Market Forecast and Analysis
10. INFLAMMATORY MARKER MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Inflammatory Marker Market Overview
10.1.2 North America Inflammatory Marker Market Forecasts and Analysis
10.1.3 North America Inflammatory Marker Market Forecasts and Analysis - By Product Type
10.1.4 North America Inflammatory Marker Market Forecasts and Analysis - By Application
10.1.5 North America Inflammatory Marker Market Forecasts and Analysis - By End User
10.1.6 North America Inflammatory Marker Market Forecasts and Analysis - By Countries
10.1.6.1 United States Inflammatory Marker Market
10.1.6.1.1 United States Inflammatory Marker Market by Product Type
10.1.6.1.2 United States Inflammatory Marker Market by Application
10.1.6.1.3 United States Inflammatory Marker Market by End User
10.1.6.2 Canada Inflammatory Marker Market
10.1.6.2.1 Canada Inflammatory Marker Market by Product Type
10.1.6.2.2 Canada Inflammatory Marker Market by Application
10.1.6.2.3 Canada Inflammatory Marker Market by End User
10.1.6.3 Mexico Inflammatory Marker Market
10.1.6.3.1 Mexico Inflammatory Marker Market by Product Type
10.1.6.3.2 Mexico Inflammatory Marker Market by Application
10.1.6.3.3 Mexico Inflammatory Marker Market by End User
10.2. EUROPE
10.2.1 Europe Inflammatory Marker Market Overview
10.2.2 Europe Inflammatory Marker Market Forecasts and Analysis
10.2.3 Europe Inflammatory Marker Market Forecasts and Analysis - By Product Type
10.2.4 Europe Inflammatory Marker Market Forecasts and Analysis - By Application
10.2.5 Europe Inflammatory Marker Market Forecasts and Analysis - By End User
10.2.6 Europe Inflammatory Marker Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Inflammatory Marker Market
10.2.6.1.1 Germany Inflammatory Marker Market by Product Type
10.2.6.1.2 Germany Inflammatory Marker Market by Application
10.2.6.1.3 Germany Inflammatory Marker Market by End User
10.2.6.2 France Inflammatory Marker Market
10.2.6.2.1 France Inflammatory Marker Market by Product Type
10.2.6.2.2 France Inflammatory Marker Market by Application
10.2.6.2.3 France Inflammatory Marker Market by End User
10.2.6.3 Italy Inflammatory Marker Market
10.2.6.3.1 Italy Inflammatory Marker Market by Product Type
10.2.6.3.2 Italy Inflammatory Marker Market by Application
10.2.6.3.3 Italy Inflammatory Marker Market by End User
10.2.6.4 Spain Inflammatory Marker Market
10.2.6.4.1 Spain Inflammatory Marker Market by Product Type
10.2.6.4.2 Spain Inflammatory Marker Market by Application
10.2.6.4.3 Spain Inflammatory Marker Market by End User
10.2.6.5 United Kingdom Inflammatory Marker Market
10.2.6.5.1 United Kingdom Inflammatory Marker Market by Product Type
10.2.6.5.2 United Kingdom Inflammatory Marker Market by Application
10.2.6.5.3 United Kingdom Inflammatory Marker Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Inflammatory Marker Market Overview
10.3.2 Asia-Pacific Inflammatory Marker Market Forecasts and Analysis
10.3.3 Asia-Pacific Inflammatory Marker Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Inflammatory Marker Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Inflammatory Marker Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Inflammatory Marker Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Inflammatory Marker Market
10.3.6.1.1 Australia Inflammatory Marker Market by Product Type
10.3.6.1.2 Australia Inflammatory Marker Market by Application
10.3.6.1.3 Australia Inflammatory Marker Market by End User
10.3.6.2 China Inflammatory Marker Market
10.3.6.2.1 China Inflammatory Marker Market by Product Type
10.3.6.2.2 China Inflammatory Marker Market by Application
10.3.6.2.3 China Inflammatory Marker Market by End User
10.3.6.3 India Inflammatory Marker Market
10.3.6.3.1 India Inflammatory Marker Market by Product Type
10.3.6.3.2 India Inflammatory Marker Market by Application
10.3.6.3.3 India Inflammatory Marker Market by End User
10.3.6.4 Japan Inflammatory Marker Market
10.3.6.4.1 Japan Inflammatory Marker Market by Product Type
10.3.6.4.2 Japan Inflammatory Marker Market by Application
10.3.6.4.3 Japan Inflammatory Marker Market by End User
10.3.6.5 South Korea Inflammatory Marker Market
10.3.6.5.1 South Korea Inflammatory Marker Market by Product Type
10.3.6.5.2 South Korea Inflammatory Marker Market by Application
10.3.6.5.3 South Korea Inflammatory Marker Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Inflammatory Marker Market Overview
10.4.2 Middle East and Africa Inflammatory Marker Market Forecasts and Analysis
10.4.3 Middle East and Africa Inflammatory Marker Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Inflammatory Marker Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Inflammatory Marker Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Inflammatory Marker Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Inflammatory Marker Market
10.4.6.1.1 South Africa Inflammatory Marker Market by Product Type
10.4.6.1.2 South Africa Inflammatory Marker Market by Application
10.4.6.1.3 South Africa Inflammatory Marker Market by End User
10.4.6.2 Saudi Arabia Inflammatory Marker Market
10.4.6.2.1 Saudi Arabia Inflammatory Marker Market by Product Type
10.4.6.2.2 Saudi Arabia Inflammatory Marker Market by Application
10.4.6.2.3 Saudi Arabia Inflammatory Marker Market by End User
10.4.6.3 U.A.E Inflammatory Marker Market
10.4.6.3.1 U.A.E Inflammatory Marker Market by Product Type
10.4.6.3.2 U.A.E Inflammatory Marker Market by Application
10.4.6.3.3 U.A.E Inflammatory Marker Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Inflammatory Marker Market Overview
10.5.2 South and Central America Inflammatory Marker Market Forecasts and Analysis
10.5.3 South and Central America Inflammatory Marker Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Inflammatory Marker Market Forecasts and Analysis - By Application
10.5.5 South and Central America Inflammatory Marker Market Forecasts and Analysis - By End User
10.5.6 South and Central America Inflammatory Marker Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Inflammatory Marker Market
10.5.6.1.1 Brazil Inflammatory Marker Market by Product Type
10.5.6.1.2 Brazil Inflammatory Marker Market by Application
10.5.6.1.3 Brazil Inflammatory Marker Market by End User
10.5.6.2 Argentina Inflammatory Marker Market
10.5.6.2.1 Argentina Inflammatory Marker Market by Product Type
10.5.6.2.2 Argentina Inflammatory Marker Market by Application
10.5.6.2.3 Argentina Inflammatory Marker Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INFLAMMATORY MARKER MARKET, KEY COMPANY PROFILES
12.1. MERCK AND CO., INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CAYMAN CHEMICAL
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BODITECH MED INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ABBOTT
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. THERMO FISHER SCIENTIFIC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ORION DIAGNOSTICA OY
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ORTHO CLINICAL DIAGNOSTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. GETEIN BIOTECH, INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
12.10. GETEIN BIOTECH, INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Inflammatory Marker Market - By Product Type
1.3.2 Inflammatory Marker Market - By Application
1.3.3 Inflammatory Marker Market - By End User
1.3.4 Inflammatory Marker Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFLAMMATORY MARKER MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INFLAMMATORY MARKER MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. INFLAMMATORY MARKER MARKET - GLOBAL MARKET ANALYSIS
6.1. INFLAMMATORY MARKER - GLOBAL MARKET OVERVIEW
6.2. INFLAMMATORY MARKER - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INFLAMMATORY MARKER MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. INTERLUKIN
7.3.1. Overview
7.3.2. Interlukin Market Forecast and Analysis
7.4. C REACTIVE PROTEIN
7.4.1. Overview
7.4.2. C Reactive Protein Market Forecast and Analysis
7.5. LEPITINE
7.5.1. Overview
7.5.2. Lepitine Market Forecast and Analysis
7.6. TUMOR NECROSIS FACTOR
7.6.1. Overview
7.6.2. Tumor Necrosis Factor Market Forecast and Analysis
7.7. CELLULAR ADHESION MOLECULE
7.7.1. Overview
7.7.2. Cellular Adhesion Molecule Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. INFLAMMATORY MARKER MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. TUMORS
8.3.1. Overview
8.3.2. Tumors Market Forecast and Analysis
8.4. ARTHRITIS
8.4.1. Overview
8.4.2. Arthritis Market Forecast and Analysis
8.5. MULTIPLE SCLEROSIS
8.5.1. Overview
8.5.2. Multiple Sclerosis Market Forecast and Analysis
8.6. OTHER APPLICATIONS
8.6.1. Overview
8.6.2. Other Applications Market Forecast and Analysis
9. INFLAMMATORY MARKER MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTICS
9.4.1. Overview
9.4.2. Diagnostics Market Forecast and Analysis
9.5. RESEARCH LABORATORIES
9.5.1. Overview
9.5.2. Research Laboratories Market Forecast and Analysis
10. INFLAMMATORY MARKER MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Inflammatory Marker Market Overview
10.1.2 North America Inflammatory Marker Market Forecasts and Analysis
10.1.3 North America Inflammatory Marker Market Forecasts and Analysis - By Product Type
10.1.4 North America Inflammatory Marker Market Forecasts and Analysis - By Application
10.1.5 North America Inflammatory Marker Market Forecasts and Analysis - By End User
10.1.6 North America Inflammatory Marker Market Forecasts and Analysis - By Countries
10.1.6.1 United States Inflammatory Marker Market
10.1.6.1.1 United States Inflammatory Marker Market by Product Type
10.1.6.1.2 United States Inflammatory Marker Market by Application
10.1.6.1.3 United States Inflammatory Marker Market by End User
10.1.6.2 Canada Inflammatory Marker Market
10.1.6.2.1 Canada Inflammatory Marker Market by Product Type
10.1.6.2.2 Canada Inflammatory Marker Market by Application
10.1.6.2.3 Canada Inflammatory Marker Market by End User
10.1.6.3 Mexico Inflammatory Marker Market
10.1.6.3.1 Mexico Inflammatory Marker Market by Product Type
10.1.6.3.2 Mexico Inflammatory Marker Market by Application
10.1.6.3.3 Mexico Inflammatory Marker Market by End User
10.2. EUROPE
10.2.1 Europe Inflammatory Marker Market Overview
10.2.2 Europe Inflammatory Marker Market Forecasts and Analysis
10.2.3 Europe Inflammatory Marker Market Forecasts and Analysis - By Product Type
10.2.4 Europe Inflammatory Marker Market Forecasts and Analysis - By Application
10.2.5 Europe Inflammatory Marker Market Forecasts and Analysis - By End User
10.2.6 Europe Inflammatory Marker Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Inflammatory Marker Market
10.2.6.1.1 Germany Inflammatory Marker Market by Product Type
10.2.6.1.2 Germany Inflammatory Marker Market by Application
10.2.6.1.3 Germany Inflammatory Marker Market by End User
10.2.6.2 France Inflammatory Marker Market
10.2.6.2.1 France Inflammatory Marker Market by Product Type
10.2.6.2.2 France Inflammatory Marker Market by Application
10.2.6.2.3 France Inflammatory Marker Market by End User
10.2.6.3 Italy Inflammatory Marker Market
10.2.6.3.1 Italy Inflammatory Marker Market by Product Type
10.2.6.3.2 Italy Inflammatory Marker Market by Application
10.2.6.3.3 Italy Inflammatory Marker Market by End User
10.2.6.4 Spain Inflammatory Marker Market
10.2.6.4.1 Spain Inflammatory Marker Market by Product Type
10.2.6.4.2 Spain Inflammatory Marker Market by Application
10.2.6.4.3 Spain Inflammatory Marker Market by End User
10.2.6.5 United Kingdom Inflammatory Marker Market
10.2.6.5.1 United Kingdom Inflammatory Marker Market by Product Type
10.2.6.5.2 United Kingdom Inflammatory Marker Market by Application
10.2.6.5.3 United Kingdom Inflammatory Marker Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Inflammatory Marker Market Overview
10.3.2 Asia-Pacific Inflammatory Marker Market Forecasts and Analysis
10.3.3 Asia-Pacific Inflammatory Marker Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Inflammatory Marker Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Inflammatory Marker Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Inflammatory Marker Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Inflammatory Marker Market
10.3.6.1.1 Australia Inflammatory Marker Market by Product Type
10.3.6.1.2 Australia Inflammatory Marker Market by Application
10.3.6.1.3 Australia Inflammatory Marker Market by End User
10.3.6.2 China Inflammatory Marker Market
10.3.6.2.1 China Inflammatory Marker Market by Product Type
10.3.6.2.2 China Inflammatory Marker Market by Application
10.3.6.2.3 China Inflammatory Marker Market by End User
10.3.6.3 India Inflammatory Marker Market
10.3.6.3.1 India Inflammatory Marker Market by Product Type
10.3.6.3.2 India Inflammatory Marker Market by Application
10.3.6.3.3 India Inflammatory Marker Market by End User
10.3.6.4 Japan Inflammatory Marker Market
10.3.6.4.1 Japan Inflammatory Marker Market by Product Type
10.3.6.4.2 Japan Inflammatory Marker Market by Application
10.3.6.4.3 Japan Inflammatory Marker Market by End User
10.3.6.5 South Korea Inflammatory Marker Market
10.3.6.5.1 South Korea Inflammatory Marker Market by Product Type
10.3.6.5.2 South Korea Inflammatory Marker Market by Application
10.3.6.5.3 South Korea Inflammatory Marker Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Inflammatory Marker Market Overview
10.4.2 Middle East and Africa Inflammatory Marker Market Forecasts and Analysis
10.4.3 Middle East and Africa Inflammatory Marker Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Inflammatory Marker Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Inflammatory Marker Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Inflammatory Marker Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Inflammatory Marker Market
10.4.6.1.1 South Africa Inflammatory Marker Market by Product Type
10.4.6.1.2 South Africa Inflammatory Marker Market by Application
10.4.6.1.3 South Africa Inflammatory Marker Market by End User
10.4.6.2 Saudi Arabia Inflammatory Marker Market
10.4.6.2.1 Saudi Arabia Inflammatory Marker Market by Product Type
10.4.6.2.2 Saudi Arabia Inflammatory Marker Market by Application
10.4.6.2.3 Saudi Arabia Inflammatory Marker Market by End User
10.4.6.3 U.A.E Inflammatory Marker Market
10.4.6.3.1 U.A.E Inflammatory Marker Market by Product Type
10.4.6.3.2 U.A.E Inflammatory Marker Market by Application
10.4.6.3.3 U.A.E Inflammatory Marker Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Inflammatory Marker Market Overview
10.5.2 South and Central America Inflammatory Marker Market Forecasts and Analysis
10.5.3 South and Central America Inflammatory Marker Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Inflammatory Marker Market Forecasts and Analysis - By Application
10.5.5 South and Central America Inflammatory Marker Market Forecasts and Analysis - By End User
10.5.6 South and Central America Inflammatory Marker Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Inflammatory Marker Market
10.5.6.1.1 Brazil Inflammatory Marker Market by Product Type
10.5.6.1.2 Brazil Inflammatory Marker Market by Application
10.5.6.1.3 Brazil Inflammatory Marker Market by End User
10.5.6.2 Argentina Inflammatory Marker Market
10.5.6.2.1 Argentina Inflammatory Marker Market by Product Type
10.5.6.2.2 Argentina Inflammatory Marker Market by Application
10.5.6.2.3 Argentina Inflammatory Marker Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INFLAMMATORY MARKER MARKET, KEY COMPANY PROFILES
12.1. MERCK AND CO., INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CAYMAN CHEMICAL
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BODITECH MED INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ABBOTT
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. THERMO FISHER SCIENTIFIC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ORION DIAGNOSTICA OY
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ORTHO CLINICAL DIAGNOSTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. GETEIN BIOTECH, INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
12.10. GETEIN BIOTECH, INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Merck & Co., Inc.
2. Novartis AG
3. Cayman Chemical
4. BODITECH MED INC
5. Abbott
6. F. Hoffmann-La Roche Ltd
7. Thermo Fisher Scientific
8. Orion Diagnostica Oy
9. Ortho Clinical Diagnostics
10. Getein Biotech, Inc
1. Merck & Co., Inc.
2. Novartis AG
3. Cayman Chemical
4. BODITECH MED INC
5. Abbott
6. F. Hoffmann-La Roche Ltd
7. Thermo Fisher Scientific
8. Orion Diagnostica Oy
9. Ortho Clinical Diagnostics
10. Getein Biotech, Inc